24 Hrs helpline: +91-11-30403040

Dr. Chandragouda Dodagoudar

Sr. Consultant
Medical Oncology

 

Qualification

  • MBBS
  • MD (Medicine)
  • DNB (Medical Oncology)
  • ECMO (Europe)


Experience

Presently working as Sr. Consultant in Medical Oncology department at BLK Super Speciality Hospital, New Delhi

 

Previous Experience:

  • Consultant - Rajiv Gandhi Cancer Hospital, Delhi  
  • Senior Resident - Max Healthcare, New Delhi
  • Senior Resident - Apollo Hospitals, Bangalore

 

 


Awards and Achievements

  • Best Resident Doctor award at RGCI and RC- Received an award from Honorable Vice President of India
  • Bharat Jyoti Award from NGO - India International Friendship Society
  • 2nd Prize in Medical Quiz for post graduates at Diamond APICON Medicine Conference Bombay, India


Membership

  • Delhi Medical Council
  • Karnataka Medical Council

 

Publications:

  • Singh J, Thota N, Singh S, Padhi S, Mohan P, Deshwal S, Sur S, Ghosh M, Dodagoudar C, et al. Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations. Breast Cancer Res Treat. 2018;170(1):189-196.
  • A prospective observational multicentric pan India study of Lenvatinib in radioiodine refractory advanced differentiated thyroid cancer May 2018 J CLIN ONCOL.
  • Carcinomatosis meningitis - A rare site of progression in carcinoma gall bladder” Accepted for approval (Article Ref. No.: 2730/13/J/DGJ) Journal, Indian Academy Of Clinical Medicine (JIACM).
  • Neuroendocrine carcinoma of gall bladder: A series of 19 cases with review of literature: J.Gastrointest (anc 10.1007/512029-015
  • Small cell carcinoma of the ovary of hypercalcemic type: National journal of medical research: Volume 4 / Issue 1/ Jan - Mar 2014.
  • Fayal hematogenous relapse of mucinous borderline ovarian tumor of intestinal type. Indian journal of Medical & Paediatric Oncology / 2013 Volume: 34/ Issue: 2/ Page: 134-135.
  • Efficacy & Safety of intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer in Indian population. Indian journal of cancer/ Nov2013/ Volume 50/ Supplement.
  • Neoadjuvant chemotherapy followed by radical surgery as management of stage IB2-IIIA cervical cancer in Indian population. Indian journal of cancer/Nov2013/Volume 50/Supplement.
  • Efficacy & safety profile of gemcitabine & erlotinib combination in advanced Ca pancreas in India. Indian journal of cancer/ Nov 2013/ Volume 50/ Supplement.
  • Imatinib in chronic myeloid leukemia: Experience in North Indian population. Indian journal of cancer/ Nov2013.Volume 50/ Supplement.
  • Efficacy & toxicity of Folfox -4 as second line chemotherapy in locally advanced unresectable & metastatic carcinoma gall bladder: A prospective observational study./2014 ASCO Annual Meeting Abstracts. JClin Oncol32, 2014 (suppl; abstre15101) e carcinoma


OPD Schedule

Days: Mon - Sat

 

Time: 9:00 am to 5:00 pm

 

 

Room: OPD-7

 

 

Make An Appointment

a passion for healing...